Because this protein is overexpressed in T cells with a loss of function within the tumor tissue of GBM and it triggers an immune evasion like that mediated by PD-1, it could be a future therapeutic option for this tumor [74]. The gene discussed is PDCD1; the disease is glioblastoma.